The turnover of Dr. Reddy's Laboratories for the financial year 2024 exceeded 279 billion Indian rupees.
Financial Performance of Dr. Reddy's Laboratories
Dr. Reddy's Laboratories, a leading pharmaceutical company, reported a robust financial performance in the most recent fiscal period. The company's turnover, often interchangeably referred to as revenue, indicates the total sales generated from its operations over a specific period.
Key Turnover Figures
For the financial year 2024, Dr. Reddy's Laboratories' revenue surpassed 279 billion Indian rupees. This figure represents a notable increase when compared to its performance in the preceding financial year.
To provide a clear overview, here is a summary of the latest reported turnover:
| Metric | Value | Financial Year | Source (Data as of) |
|---|---|---|---|
| Total Turnover (Revenue) | Over 279 billion INR | 2024 | Statista |
Understanding Turnover
Turnover is a critical financial metric that represents the total value of sales made by a company during a specific accounting period. It serves as an important indicator of a company's operational scale and market presence. For a pharmaceutical company like Dr. Reddy's Laboratories, turnover primarily includes sales from its various drug formulations, active pharmaceutical ingredients (APIs), and other healthcare products across its global markets. An increase in turnover generally signifies business growth, successful product launches, and expanded market reach.
